Directory
>
Ralu Vlad
Ralu Vlad
Vice President and Head of Medical Evidence Generation | Bristol Myers Squibb
United States
Ralu Vlad
Summary
Ralu Vlad is a seasoned executive with extensive experience in medical affairs and clinical development, particularly in the field of Immuno-Oncology. As the Vice President and Head of Medical Evidence Generation at Bristol Myers Squibb, he has successfully led complex global development programs and fostered high-performing teams. His leadership is characterized by a commitment to talent development and organizational growth. Ralu has a proven track record in product commercialization and health authority interactions, making him a valuable asset in the pharmaceutical industry. His academic background includes a Pharm.D. from Rutgers University, equipping him with a strong foundation in pharmacy. Ralu's career is marked by significant roles at Bristol Myers Squibb and Novartis, where he has specialized in oncology and clinical research. He is passionate about driving innovation and improving patient outcomes through strategic medical initiatives.
Ralu Vlad
Work Experience
Vice President and Head of Medical Evidence Generation at
Bristol Myers Squibb
November 2022 - Present
Vice President, Development Team Lead at
BRISTOL MYERS SQUIBB FARMACEUTICA
January 2018 - December 2022
Executive Director, Global Strategic Collaborations at
BRISTOL MYERS SQUIBB FARMACEUTICA
March 2016 - December 2017
Director, US Liaison, Global Regulatory Strategy - Oncology at
Bristol Myers Squibb
June 2013 - March 2016
Medical Director, Global Medical Affairs Oncology at
Bristol Myers Squibb
June 2010 - June 2013
Director, Medical Strategy, US - Oncology at
Bristol Myers Squibb
May 2007 - June 2010
Associate Director, Medical Strategy - Oncology at
Bristol Myers Squibb
May 2006 - May 2007
Sr. Clinical Research Scientist - Oncology at
NOVARTIS PHARMACEUTICALS (HK) LIMITED
May 2003 - May 2006
Post Doctoral Fellow, Hoffman-La Roche & Rutgers Univ. at
Rutgers University Ernest Mario School Of Pharmacy
July 2001 - May 2003
Ralu Vlad
Education
Rutgers University, Pharm.D., Bs
January 1995 - January 2001
Frequently Asked Questions about Ralu Vlad
What is Ralu Vlad email address?
Ralu Vlad's primary email address is *********@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ralu Vlad work for?
Ralu Vlad is a Vice President and Head of Medical Evidence Generation at Bristol Myers Squibb, a company specializing in Biological products, except diagnostic.
Where Ralu Vlad graduated from?
Ralu Vlad holds a degree in Pharmacy from Rutgers University.
How can I directly contact Ralu Vlad?
To contact Ralu Vlad directly, you can use the email address *********@bms.com. Complete contact information is available upon registration with Muraena.
Who is Ralu Vlad?
Ralu Vlad is a seasoned executive with extensive experience in medical affairs and clinical development, particularly in the field of Immuno-Oncology. As the Vice President and Head of Medical Evidence Generation at Bristol Myers Squibb, he has successfully led complex global development programs and fostered high-performing teams. His leadership is characterized by a commitment to talent development and organizational growth. Ralu has a proven track record in product commercialization and health authority interactions, making him a valuable asset in the pharmaceutical industry. His academic background includes a Pharm.D. from Rutgers University, equipping him with a strong foundation in pharmacy. Ralu's career is marked by significant roles at Bristol Myers Squibb and Novartis, where he has specialized in oncology and clinical research. He is passionate about driving innovation and improving patient outcomes through strategic medical initiatives.
Ralu`s contact details
*********@bms.com
Colleagues
Vice President Informatics & Predictive Sciences at Bristol Myers Squibb
Executive Director, US Hematology Marketing
Executive Director, Clinical Data Acquisition
Vice President, Head of Worldwide Commercialization Strategy & Operations
Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology
Vice President, Cell Therapy Commercial Organization
VP External Manufacturing Biologics
Associate Director, Commercial Data Science & Decision Analytics
Executive Director Head of Clinical Evaluation and Collaborations, Immunology and Fibrosis
Executive Director, Digital Health TA Lead - Cardiovascular and Neuroscience